BioCatalystWatch
PYXSWorkspace / PYXS / OverviewCompany library
Pyxis Oncology, Inc. logo

Pyxis Oncology, Inc.

Pyxis Oncology, Inc. (PYXS)

Website

Price
Market cap
Next catalystDec 2026MICVO + pembrolizumab — PYX-201-102 · Phase 1/2 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

MICVOMICVO + pembrolizumab — PYX-201-102

EDB+FN

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

MICVO

EDB+FN

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

MICVO

EDB+FN

Upcoming / outlook

MICVO

EDB+FN

PreINDP1P2FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

MICVO

EDB+FN

Upcoming / outlook

MICVOMICVO + pembrolizumab — PYX-201-102

EDB+FN

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

MICVO

EDB+FN

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

MICVO

EDB+FN

PreINDP1P2FilingApproved
Upcoming / outlook

Approved / commercial

History / paused

CD123

PreINDP1P2P3FilingApproved

CD40

PreINDP1P2P3FilingApproved

CD40

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

PYXS PR & News

PR & News

PYXS SEC archive